Why Compounded Drugs Are Not FDA-Approved Drugs
Compounding can serve legitimate patient needs under defined legal conditions, but compounded products do not undergo FDA premarket approval.
Approval and compounding are different regulatory pathways. Conflating them obscures what has and has not been reviewed.
FDA approval evaluates a specific product
An approved drug is reviewed for a defined formulation, manufacturing process, controls, labeling, and intended use. The review considers evidence of safety and effectiveness and whether the product can be manufactured consistently under applicable requirements.
Compounding operates through statutory exemptions
Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act create pathways under which qualifying compounded drugs may be exempt from certain approval, labeling, and manufacturing provisions. The conditions differ between traditional pharmacies and outsourcing facilities.
Compounded drugs are not preapproved
FDA does not verify the safety, effectiveness, or quality of each compounded product before it reaches a patient. State boards of pharmacy and FDA share oversight in different ways depending on the facility and activity.
'Generic' is not the correct shortcut
An FDA-approved generic must demonstrate required sameness and bioequivalence to a reference product and be manufactured under an approved application. A compounded product is not an approved generic merely because it contains an ingredient with the same name.
Quality is product-specific
Source material, formulation, concentration, excipients, sterility controls, container closure, stability, and handling can all differ. Evidence associated with an approved product does not automatically establish the quality or clinical performance of a compounded version.
Communication should be precise
Businesses should clearly identify whether a product is FDA approved, compounded, investigational, or supplied for research. Ambiguous phrases such as pharmaceutical grade or FDA registered can create a misleading impression if they imply approval.
This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.
molecule-level science is separate from product-level regulatory status. An ingredient may be well studied while a particular preparation remains unapproved and unevaluated.
Selected primary references
Editorial note. Written by Jacob Leisher and scientifically reviewed by Jacob Doyon. See our editorial standards, citation policy, and corrections policy.
Continue reading
What Makes a Peptide Different From a Protein or Small Molecule?
Peptides occupy a distinct scientific space between traditional small molecules and larger proteins. Understanding that distinction is essential for interpreting research, evaluating material identity, and designing reproducible experiments.
FundamentalsWhy Peptide Structure Matters: Sequence, Conformation, and Biological Activity
Even a single amino-acid substitution can change receptor affinity, stability, selectivity, or degradation. Peptide structure is not a footnote, it is the foundation of the experiment.
StructureLinear vs Cyclic Peptides: How Structure Changes Research Behavior
Cyclization can improve stability and constrain a peptide into a useful binding shape, but it also creates new design and analytical tradeoffs.